S.R.Y (Medical Services) LTD operates the Cyclotron Unit at Hadassah Medical Organization (HMO), Jerusalem, Israel, which has been engaged in nuclear medicine for over 20 years. The company produces radiopharmaceuticals in state-of-the-art manufacturing facilities, according to Israeli Ministry of Health regulations. S.R.Y is a leading company in the national radiopharmaceutical market, providing service to over 10 client hospitals in Israel.

S.R.Y is equipped with the most advanced technology, and produces radiopharmaceuticals according to uncompromising standards, which meet the most stringent pharmaceutical criteria. The company owns two 18 MeV IBA cyclotrons, four 68Ge-68Ga generators, ten automated modules and two clean rooms for production, containing hot cells and ‘Grade A’ isolators for production of a wide range of radiopharmaceuticals. The quality control tests are carried out using cutting-edge analytical apparatuses.

S.R.Y’s CEO, Professor Eyal Mishani, is among the world's pioneers in the field of radiochemistry and PET pharmaceuticals, with almost 30 years of experience. Prof. Mishani serves as a global expert in quality assurance in nuclear medicine on behalf of the International Atomic Energy Agency (IAEA). S.R.Y’s personnel includes three PhD's in chemistry, biology and pharmacology, physicists, biologists, engineers, pharmacists and additional specialized personnel.

S.R.Y operates at the forefront of science and technology and is engaged in research and development of new radiopharmaceuticals. By doing so, the company aims to promote the field of PET molecular imaging and patient care, both at the national and the international levels.